Long-term use of nonsteroidal antiinflammatory drugs and the risk of colorectal adenomas

Digestion

Volumn 61, Issue 2, 2000, Pages 129-134

  Breuer Katschinski, B ^a   Nemes, K ^a   Rump, B ^a   Leiendecker, B ^a   Marr, A ^a   Breuer, N ^a   Goebell, H ^a  

^a NONE

Author keywords

Colorectal adenomas; Epidemiology; NSAID intake

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER RISK; CASE CONTROL STUDY; COLON POLYP; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0034004226     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007745     Document Type: Article

References (27)

1. Kune GA, Kune S, Watson LF: Colorectal cancer risk, chronic illness, operations, and medications: Case-control results from the Melbourne Colorectal Cancer Study. Cancer Res 1988;48:4399-4404.
2. Paganini-Hill A, Chao A, Ross RK, Henderson BE: Aspirin use and chronic disease: A cohort study of the elderly. Br Med J 1989;299:1247-1250.
3. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S: A hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large bowel cancer. J Natl Cancer Inst 1991;83:355-358.
4. Thun MJ, Namboodiri MM, Heath CW: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-1596.
5. Gridley G, McLaughin JK, Ekbom A, et al: Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993;85: 307-311.
6. Suh O, Mettlin C, Petrelli NJ: Aspirin use, cancer, and polyps of the large bowel. Cancer 1993; 72:1171-1177.
7. Greenberg ER, Baron JA, Freeman TH, Mandel SJ, Haile R: Reduced risk of large bowel adenomas among aspirin users: The Polyp Prevention Study Group. J Natl Cancer Inst 1993; 85:912-916.
8. Pollard M, Luckert PH: Indomethacin treatment of rats with dimetylhydrazine-induced intestinal tumors. Cancer Treat Rep 1980;64: 1323-1327.
9. Narisawa T, Sato M, Tani M, Kudo T, Takahashi T, Goto A: Inhibition of development of methylnitrosurea-induced rat colon tumors by indomethacin treatment. Cancer Res 1981;41: 1954-1957.
10. Pollard M, Luckert PH: Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science 1981;214:558-559.
11. Martinez ME, McPherson RS, Levin B, Annegers JF: Aspirin and other nonsteroidal antiinflammatory drugs and risk of colorectal adenomatous polyps among endoscoped indiviuals. Cancer Epid Biom Prev 1995;4:703-707.
12. Thun MJ, Namhoodiri MM, Calle EF, Flanders WD, Heath CW Jr: Aspirin use and risk of fatal cancer. Cancer Res 1993;53:1322-1327.
13. Schreinemachers DM, Everson R: Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994;5: 138-146.
14. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willet WC: Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994;121:241-246.
15. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willet WC, Speizer FE: Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995;333:609-614.
16. Gridley G, McLaughlin JK, Ekbom A, et al: Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993;85: 307-311.
17. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, et al: Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991;101:635-639.
18. Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH: Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 1993;85:1220-1224.
19. Logan RF, Little J, Hawtin PG, Hardcastle JD: Effect of aspirin and nonsteroidal anti-inflammatory drugs on colorectal adenomas: Case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br Med J 1993;307:285-289.
20. Boutron MC, Faivre J, Milan C, Lorceric B, Estcve J: A comparison of two diet history questionnaires that measure usual food intake. Nutr Cancer 1989;12:83-91.
21. Rothman KJ: Modern Epidemiology. Boston, Little Brown, 1986.
22. Cauvin JM, Goldfain D, Le Rhun M, Robaszkewicz M, Cadiot G, Carpentier S, et al: Multicentre prospective controlled study of Barrett's oesophagus and colorectal adenomas, Groupe d'Etude de l'Oesophage de Barret. Lancet 1996;347:66-67.
23. Rex DK, Lehmann GA, Hawes RH, Ulbright TM, Smith JJ: Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology 1991;100:64-67.
24. Liebermann DA, Smith FW: Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991;86:946-951.
25. Breuer-Katschinski B, Nemes K, Rump B, Leiendecker B, Breuer N, Goebell H, and Colorectal Adenoma Study Group: Colorectal adenomas and diet. In prep.
26. Marnett LJ: Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 1992;52:5575-5589.
27. 2 suppresses the increases in the proliferative activity of rat colonic epithelium induced by indomethacin and aspirin. Gastroenterology 1985;89:1054-1063.